grant

The identification of novel targets and therapeutic agents in the treatment of triple negative breast cancer. [ 2011 - 2016 ]

Also known as: The identification of novel treatments for poor prognosis subgroups of breast cancer.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1013525]

Researchers: A/Pr Elgene Lim (Principal investigator)

Brief description Triple negative breast cancer constitutes 15-20% of breast cancers, occuring at higher frequency in younger women and has a disproportionately higher mortality compared to other breast cancer subtypes. They are often resistant to chemotherapy and there are currently no established therapeutic targets to enhance or replace conventional treatment. My study aims to identify novel targets and therapeutic strategies for this aggressive breast cancer subtype, in the hope of improving patient outcomes.

Funding Amount $AUD 365,875.26

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857